BASF anticipates to increase sales at its pharmaceutical finishing services business.

BASF anticipates to increase sales at its pharmaceutical finishing services business, including tablet and formulation activities, by dint of almost 10% this year and annually for the nearest few years, from a "substantial" base, says Patrick Glaser, director/Pharma Solutions for BASF North America. BASF says

Want to read the whole article? You can purchase it here. It's quick and easy....